Intra- and interindividual variability in fasted gastric content volume

2 Abstract

Background Gastric fluid plays a key role in food digestion and drug dissolution, therefore, the amount of gastric fluid present in a fasted state may influence subsequent digestion and drug delivery. We aimed to describe intra- and interindividual variation in fasted gastric content volume (FGCV) and to determine the association with age, sex, and body size characteristics.

Methods Data from 24 MRI studies measuring FGCV in healthy, mostly young individuals after an overnight fast were pooled. Analysis included 366 participants with a total of 870 measurements. Linear mixed model analysis was performed to calculate intra- and interindividual variability and to assess the effects of age, sex, weight, height, weight*height as a proxy for body size, and body mass index (BMI).

Results FGCV ranged from 0 to 156 mL, with a mean (± SD) value of 33 ± 25 mL. The overall coefficient of variation within the study population was 75.6%, interindividual SD was 15 mL, and the intraindividual SD was 19 mL. Age, weight, height, weight*height, and BMI had no effect on FGCV. Women had lower volumes compared to men (MD: -6 mL), when corrected for the aforementioned factors.

Conclusion FGCV is highly variable, with higher intraindividual compared to interindividual variability, indicating that FGCV is subject to day-to-day and within-day variation and is not a stable personal characteristic. This highlights the importance of considering FGCV when studying digestion and drug dissolution. Exact implications remain to be studied.

• Download figure
• Open in new tab

KEY POINTS

• Fasted gastric content volume is highly variable, both within an individual and between individuals, and should range between 0 and 138 mL in healthy young individuals.

• Women have lower fasted gastric content volume compared to men; age, body weight and body size were not associated with differences in fasted gastric content volume.

• Fasted gastric content volume can impact both digestion and drug dissolution, although exact implications of the observed variations remain to be studied.

Competing Interest Statement

DNL has received an unrestricted educational grant from B Braun and speakers honoraria from Nestle, Abbott and Corza for unrelated work. RS has received research grants from Zespri International and Sanofi and speakers fees from Ardelyx, Menarini & Ferrer. All other authors declare no conflict of interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical statements of all the datasets included in the analysis in this manuscript: Alyami, et al. (2019): The study University of Nottingham, Medical School Research Ethics gave ethical approval for this work (F12072016). Camps, et al. (2021): The Medical Ethical Committee of Wageningen gave ethical approval for this work. Camps, et al. (2018): The Medical Ethical Committee of Wageningen gave ethical approval for this work (NL48059.081.14). ClinicalTrials.gov NCT05575687: The Medical Ethical Committee of Wageningen gave ethical approval for this work ClinicalTrials.gov NCT05854407: The Medical Ethical Committee of Wageningen gave ethical approval for this work. Coletta, et al. (2016): The study University of Nottingham, Medical School Research Ethics gave ethical approval for this work. Deng, et al. (2023): The Medical Ethical Committee of Wageningen gave ethical approval for this work (NL74166.081.20). Freitas, et al. (2022): The ethics committee Lyon Sud-Est IV gave ethical approval for this work (A 17 347). Grimm, et al. (2018): The ethical review board of the Ernst Moritz Arndt University of Greifswald gave ethical approval for this work (BB 079/14). Hussein, et al. (2015): The study University of Nottingham, Medical School Research Ethics gave ethical approval for this work. Juovonen, et al. (2015): The Essex 1 Research Ethics Committee gave ethical approval for this work. Krishnasamy, et al. (2020): The study University of Nottingham, Medical School Research Ethics gave ethical approval for this work. Lobo, et al. (2009): The study University of Nottingham, Medical School Research Ethics gave ethical approval for this work. Marciani, et al. (2010): The local ethics committee gave ethical approval for this work. Marciani, et al. (2012): The study University of Nottingham, Medical School Research Ethics gave ethical approval for this work. Marciani, et al. (2013): The study University of Nottingham, Medical School Research Ethics gave ethical approval for this work. Marciani, et al. (2015): The study University of Nottingham, Medical School Research Ethics gave ethical approval for this work. Mudie, et al. (2014): The local Medical School Research Ethics Committee gave ethical approval for this work. Murray, et al. (2015): The local Medical School Research Ethics Committee gave ethical approval for this work. Roelofs, Tjoelker, et al. (2024): The Medical Ethical Committee of Wageningen gave ethical approval for this work. Roelofs, van Eijnatten, et al. (2024): The Medical Ethical Committee Arnhem-Nijmegen gave ethical approval for this work. Trialsearch.who.int NL8137: The Medical Ethical Committee Arnhem-Nijmegen gave ethical approval for this work. van Eijnatten, Camps, et al. (2023): The Medical Ethical Committee of Wageningen gave ethical approval for this work (NL66536.081.18)). van Eijnatten, Roelofs, et al. (2023): The Medical Ethical Committee of Wageningen gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes